Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is an increasing public health concern. Currently, data regarding the clinical application value of plasma Galectin-3 (Gal-3) in HFpEF are contradictory. Therefore, we performed the following meta-analysis to appraise the clinical im...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yujiao, Dong, Guoju, Liu, Jiangang, Shuang, Xiong, Liu, Chunqiu, Yang, Chenguang, Qing, Wang, Qiao, Wenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046693/
https://www.ncbi.nlm.nih.gov/pubmed/35498052
http://dx.doi.org/10.3389/fcvm.2022.854501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046693/
https://www.ncbi.nlm.nih.gov/pubmed/35498052
http://dx.doi.org/10.3389/fcvm.2022.854501

Ejemplares similares